Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
MIXING: Insulin Aspart and Detemir in Children with T1D
NCT00542620Phase 4Completed
- Sponsor
- Novo Nordisk
- Start
- Sep 2007
- Primary completion
- Mar 2009
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 4, randomised, open-label trial of insulin detemir and insulin aspart in type 1 diabetes mellitus (T1D) (2 arms), sponsored by Novo Nordisk. Primary endpoint: Glycosylated Haemoglobin A1c at Week 8. Started Sep 2007; status: completed.
02
Drugs
insulin detemirinsulin aspart
03
Conditions
type 1 diabetes mellitus (T1D)
Beyond the preview
Go deeper on NCT00542620.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00542620.